ENVERIC BIOSCIENCES, INC. Net Cash Provided by (Used in) Investing Activities, Continuing Operations
ENVERIC BIOSCIENCES, INC. (ENVB) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$321.96 thousand for the 3-month period ending 2017-03-31, per its 10-Q/A filed 2017-05-15.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-05-15
- ENVERIC BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was -$321.96K.
- ENVERIC BIOSCIENCES, INC. net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-03-31 was -$1.77M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month |
|---|---|
| 2017-03-31 | -$321.96K 10-Q/A · filed 2017-05-15 |
| 2016-03-31 | -$1.77M 10-Q/A · filed 2017-05-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |